Pemtumomab
Pemtumomab
Pemtumomab (pronunciation: pem-tu-mo-mab) is a monoclonal antibody used in the treatment of certain types of cancer. It is a type of radioimmunotherapy and is sometimes referred to as a radiolabeled antibody.
Etymology
The name "Pemtumomab" is derived from parts of the phrases "PErsonalized Medicine", "TUMOr", and "MAB" (an abbreviation for monoclonal antibody).
Usage
Pemtumomab is used in the treatment of certain types of cancer, including ovarian cancer and peritoneal cancer. It works by binding to a specific protein found on the surface of cancer cells, allowing a radioactive substance to be delivered directly to the cancer cells.
Related Terms
- Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Radioimmunotherapy: A type of therapy that uses radioactive substances in combination with antibodies to treat cancer.
- Radiolabeled antibody: An antibody that has been joined with a radioactive substance, used to detect or treat cancer.
- Ovarian cancer: A type of cancer that begins in the ovaries.
- Peritoneal cancer: A rare cancer that develops in the peritoneum, a thin, delicate sheet that lines the inside wall of the abdomen and covers the uterus and extends over the bladder and rectum.
External links
- Medical encyclopedia article on Pemtumomab
- Wikipedia's article - Pemtumomab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski